ISPH researchers ask, are we repeating the same cost and insurance coverage mistakes again with injectable PrEP?
In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bi-monthly injectable pre-exposure prophylaxis […]